What BIOME Consortia does

BIOME Consortia (legally BIOME Consortia Institute) is a 501(c)(3) non-profit institution founded in 2024 and headquartered in Raleigh, North Carolina. The organization describes itself as building a global platform of experts and open-source tools to collectively map Earth's microbiome and apply microbial intelligence across industries. Its stated problem frame is that humankind has discovered only an estimated 0.001% of microbial species, and that environmental destruction and homogenization are causing irrevocable loss of ecological wisdom. Its six-person founding team spans applied biology and biocement (Ginger Krieg Dosier, Michael Dosier — both co-founders of Biomason), healthcare and deep tech (Erum Khan — prior chemist at GSK and J&J, ex-CEO of Soundmind), beauty/wellness product innovation (Rae Cutlan — L'Oreal, Kiehl's, Biophile Skincare, The Rootist, Amare), food science and venture (Mariliis Holm — founding partner of Sustainable Food Ventures, created the world's first cell-based bluefin tuna at Finless Foods), and community design (Lesli Robertson — Smithsonian, USAID, Yale CEA, Fulbright).

The organization's described core offering is a collaborative platform infrastructure for microbiome discovery together with open-source biological tools and applications intended to accelerate innovation. No named products, modules, datasets, APIs, SDKs, patents, or commercial deliverables are disclosed. Distribution and GTM are described as scientific collaboration and open-source platform operations rather than traditional commercial channels; no pricing is publicly disclosed and no customer segments, revenue model, or go-to-market motion is documented.

The business model is a non-profit research/consortium model. The organization is described as leading a "global movement" rather than selling products or services; the firmographic profile and website emphasize 501(c)(3) status and mission framing over commercial monetization. No funding rounds, grants, donors, institutional investors, partnerships, customers, or revenue figures are disclosed in the source material. The firm has 1-10 employees and an active website, indicating organizational formation and public launch rather than scaled operations.

Name

BIOME Consortia

Legal name

BIOME Consortia Institute

Website

https://biomeconsortia.org

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

1–10 employees

Short description

BIOME Consortia is a 501(c)(3) non-profit founded in 2024 in Raleigh, North Carolina, building an open-source platform of experts and biological tools to collectively map Earth's microbiome and apply microbial intelligence across industries.

Ownership category

akta.pro rank

Product category

Microbiome Research Platform

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Consortia & Defined Microbial Community Therapeutics (HLAAAFAC)

akta.pro secondary industries

Microbiome & Metagenomics Services (HLAGANAH), Microbiome Analytics, Sequencing & Bioinformatics Platforms (HLAAAFAI)

Keywords

• Microbiome research platform
• Open-source biological tools
• Microbial intelligence mapping
• Industrial microbiology applications
• Biocement biotechnology

Headquarters

HQ city

Raleigh

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Core offering

BIOME Consortia is a non-profit institution that creates a global platform of experts and open-source tools and biological applications for collectively mapping Earth's microbiome. The organization leads a movement to discover, translate, apply, and preserve microbial intelligence, unlocking the near-infinite potential of microorganisms to transform industries and foster a resilient future.

Product overview

BIOME Consortia is a non-profit institution operating as a global platform of experts and cutting-edge technology focused on discovering, translating, applying, and preserving microbial intelligence. The organization develops open-source tools and biological applications for collectively mapping Earth's microbiome to accelerate innovation. While no distinct named products or modules are explicitly listed in the available source material, the organization's offerings center on providing a collaborative platform infrastructure and open-source biological tools for the microbial research community.

Differentiator

Problem solved

Functional benefit

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves3 records

Expansion highlights4 records

Direct peers

• Earth BioGenome Project: Large-scale global consortium to sequence genomes of all eukaryotic life on Earth; highly comparable open, consortia-based biodiversity-mapping model though focused on eukaryotes rather than microbes.
• OpenBiome: Non-profit microbiome repository and platform advancing microbiome science through open collaboration; directly comparable non-profit, open-source microbiome infrastructure model.
• CosmosID: Microbiome analytics and bioinformatics platform offering sequencing-based microbial identification services; comparable microbiome analytics, sequencing, and bioinformatics tooling focus.
• Vedanta Biosciences: Develops defined, consortia-based microbiome therapeutics; directly comparable to BIOME Consortia's "consortia" focus, but operates as a venture-backed for-profit in the clinical therapeutics space.
• Earth Microbiome Project: Global collaborative effort to characterize microbial life on Earth via open data and standardized methods; the closest direct comparable to BIOME Consortia's open-source, consortia-based approach to microbiome mapping.

Emerging players

• Second Genome: Microbiome therapeutics company identifying microbial functions for drug development; comparable microbiome discovery and translation platform, but therapeutics-focused rather than open-source.
• Finless Foods: Founded by BIOME Consortia partner Mariliis Holm; cell-based seafood company applying biological science to food systems — comparable microbial/cell-based innovation in food vertical.
• Diversigen: Microbiome and metagenomics services provider for research and clinical applications; comparable metagenomics sequencing services and microbiome analytics capability.
• Biomason: Co-founded by two of BIOME Consortia's founders, pioneering biocement grown by microorganisms; direct application of microbial intelligence in materials, validating the founders' translational track record.

Broad incumbents

• Ginkgo Bioworks: Platform biotech building engineered microbes for industrial applications across food, materials, and agriculture; comparable industrial microbiology focus but at vastly larger commercial scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BIOME Consortia